Shamburg News · 8-K filed Nov 13, 2026, 5:28 PM EST
MacroGenics Furnishes Updated Corporate Presentation With Clinical Program Details
MGNX · MACROGENICS INC
- Reg FD disclosure
- Materiality: low
On November 13, 2026, MacroGenics, Inc. made available an updated corporate presentation on its website reflecting updated clinical program details. A copy of the presentation is furnished as Exhibit 99.1 under Item 7.01 (Regulation FD Disclosure) and is not deemed filed for purposes of Section 18 of the Exchange Act. The presentation, dated November 12, 2026, includes cash and marketable securities of $288 million as of September 30, 2026 and cash runway guidance through 2028.
Source: SEC EDGAR, Form 8-K, Items 7.01, 9.01, accession 0001125345-26-000077.
Written from the filing by Shamburg Markets. Figures are as reported by the company.